EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Degeneration mechanisms and advancements in optimization for preparation and crosslinking strategy of pericardium-based bioprosthetic heart valves

Xueyu Huang, Bangquan Wei, Lepeng Chen, Li Yang, Cheng Zheng, Yunbing Wang

Acta Biomaterialia · 2025-07 · 201 · 51-74

DOI: 10.1016/j.actbio.2025.05.062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2025-07. Verfasst von Xueyu Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, China. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Bioprosthesis, Pericardium, Cross-Linking Reagents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 281 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valvular heart disease (VHD), clinically manifested as the malfunction of heart valves, greatly threatens public health worldwide. The morbidity and mortality of VHD increase significantly with age, and the high prevalence of VHD in aging society has prompted the urgency for effective treatment. Prosthetic heart valve replacement is currently recognized as the gold standard for VHD treatment. Bioprosthetic heart valves (BHVs), generally manufactured from glutaraldehyde crosslinked xenogeneic tissue, exhibited better hemodynamics and lower thrombogenicity than mechanical heart valves (MHVs) and could be implanted by transcatheter valve replacement systems, which markedly improved the efficiency of VHD therapy, especially for the elderly patients. However, BHVs degenerate within 10-15 years after implantation, which is greatly associated with their defects including cytotoxicity, calcification, immune response, matrix degradation, mechanical damage, and thrombosis. To prolong the service life of BHVs, recent studies have developed a series of innovative modification strategies to improve the biocompatibility, mechanical performance, matrix components stability, anticalcification, and antithrombotic properties of conventional glutaraldehyde crosslinked BHVs. Moreover, a series of new crosslinking and modification strategies have been proposed and developed to fabricate non-glutaraldehyde crosslinked BHVs with good stability, biocompatibility, hemocompatibility, anticalcification property, durability, and hydrodynamics. In this review, we first summarized the defects of BHVs and the related reasons from the perspective of biomaterials, and then comprehensively detailed the functional modification strategies for BHVs based on glutaraldehyde crosslinking. We provided detailed insights into novel non-glutaraldehyde crosslinking and modification strategies for BHVs. Finally, the current challenges and prospects of BHVs were also discussed. STATEMENT OF SIGNIFICANCE: Bioprosthetic heart valves (BHVs) currently face challenges such as cytotoxicity, thrombosis, calcification, and immunoinflammatory responses, which contribute to structural valve degeneration and reduce the longevity of BHVs. This review provides a comprehensive introduction to the detailed defects associated with glutaraldehyde crosslinked BHVs from the perspective of biomaterials. It then thoroughly elaborates on the modification strategies based on glutaraldehyde crosslinking, as well as detailed insights into novel non-glutaraldehyde crosslinking strategies for BHVs. Finally, the challenges and prospects facing BHVs are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisBioprosthesisPericardiumCross-Linking ReagentsHumansAnimalsGlutaral

Stichwörter der Autor:innen

AnticalcificationAntithrombosisBiocompatibilityBioprosthetic heart valveModification and crosslinking strategies

Substanzen

Cross-Linking ReagentsGlutaral

Autor:innen und Institutionen

  • National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, China.
  • National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, China. Electronic address: zhengcheng@scu.edu.cn.
  • National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, China; Research Unit of Minimally Invasive Treatment of Structural Heart Disease, Chinese Academy of Medical…

Förderung

  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Huang, X., Wei, B., Chen, L., Yang, L., Zheng, C., & Wang, Y. (2025). Degeneration mechanisms and advancements in optimization for preparation and crosslinking strategy of pericardium-based bioprosthetic heart valves. Acta Biomaterialia, 201, 51-74. https://doi.org/10.1016/j.actbio.2025.05.062

Vancouver

Huang X, Wei B, Chen L, Yang L, Zheng C, Wang Y. Degeneration mechanisms and advancements in optimization for preparation and crosslinking strategy of pericardium-based bioprosthetic heart valves. Acta Biomaterialia. 2025;201:51-74. doi:10.1016/j.actbio.2025.05.062

BibTeX
@article{Huang2025,
  author = {Huang, Xueyu and Wei, Bangquan and Chen, Lepeng and Yang, Li and Zheng, Cheng and Wang, Yunbing},
  title = {Degeneration mechanisms and advancements in optimization for preparation and crosslinking strategy of pericardium-based bioprosthetic heart valves},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {201},
  pages = {51--74},
  doi = {10.1016/j.actbio.2025.05.062}
}
Kostenlos starten →